Abstract
In the realm of drug discovery, the deluge of biomedical literature poses a formidable challenge for researchers to efficiently extract relevant information. Biomedical text mining, a multidisciplinary field at the intersection of computer science and bioinformatics, has emerged as a pivotal tool to unravel the vast troves of information concealed within scientific literature. This abstract explores the synergy between Natural Language Processing (NLP) and Deep Learning (DL) techniques in the context of biomedical text mining, aiming to expedite the drug discovery process. Natural Language Processing, with its capacity to comprehend and interpret human language, serves as the foundational layer for extracting meaningful insights from biomedical texts. Leveraging advanced NLP algorithms, researchers can identify key entities such as genes, proteins, diseases, and their interactions, providing a comprehensive understanding of the biological landscape. However, the complexity and ambiguity inherent in scientific texts demand a more sophisticated approach. Deep Learning, characterized by neural networks with multiple layers, has proven instrumental in handling intricate patterns and latent relationships within biomedical data. The confluence of NLP and DL not only aids in information extraction but also fosters the creation of predictive models for drug discovery. By training models on vast datasets, researchers can predict potential drug candidates, understand drug-disease associations, and unveil novel therapeutic targets. The collaborative approach presented in this abstract embodies a paradigm shift in drug discovery, where the amalgamation of linguistic comprehension and deep learning prowess enables researchers to navigate the labyrinth of biomedical literature with unprecedented efficiency. As the biomedical landscape continues to evolve, the proposed synergistic framework serves as a beacon for researchers and industry professionals, offering a potent toolkit to harness the wealth of information concealed within textual data, ultimately accelerating the drug discovery pipeline.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.